References
- Stampfer H. The relationship between psychiatric illness and the circadian pattern of heart rate. Australian and New Zealand Journal of Psychiatry 1998; 32: 187–189
- Buckley P, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Safety 2000; 23: 215–228
- Safferman A Z, Lieberman J A, Kane J M, Szymankis S, Kinon B. Update on the clinical efficacy and side effects of clozpine. Schizophrenia Bulletin 1991; 17: 247–261
- Lieberman J A, Safferman A Z. Clinical profile of clozapine: adverse reactions and agran-ulocytosis. Psychiatric Quarterly 1992; 63: 51–70
- Bechlin T, Claus D, Weis M. Heart rate variability in schizophrenia patients and changes of autonomic heart rate parameters during treatmentwith clozapine. Biological Psychiatry 1994; 35: 888–892
- Young C B, Bowers Jr M B, Mazure C M. Management of the adverse effects of clozapine. Schizophrenia Bulletin 1998; 24: 381–390
- Miller D. Beview and management of clozapine side effects. Journal of Clinical Psychiatry 2000; 61: 14–17
- Barak P, Wittenberg N, Naor S, Kutzuk D, Weizman A. Clozapine in elderly psychiatric patients: tolerability, safety and efficacy. Comprehensive Psychiatry 1999; 40: 320–325
- Naranjo C A, Busto U, Sellers E M, et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 1981; 30: 239–245
- La Grenade L, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. New England Journal of Medicine 2001; 345: 224–225
- Hasan S, Buckley P. Novel antipsychotic and the neuroleptic malignant syndrome: a review and critique. American Journal of Psychiatry 1998; 155: 1113–1116
- Agelink M, Majewski T, Wurthmann C, et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amilsulpride, olanzapine, sertindole and clozapine. Journal of Clinical Psychopharmacology 2001; 21: 8–13
- Cohen H, Loewenthal U, Matar M, Kotler M. Heart rate variability in schizophrenic patients treated with antipsychotic agents. Harefua 2001; 140: 1142–1147
- Chengappa K N, Pollock B G, Parepally H, et al. Anticholinergic differences among pa tients receiving standard clinical doses of olanzapine or clozapine. Journal of Clinical Psychopharmacology 2000; 20: 311–316
- Palatini P. Need for a revision of the normal limits of resting heart rate. Hypertension 1999; 33: 622–625